They concluded that the overexpression of fascin-1 in cancer is unlikely to be due to epigenetic regulation, but rather to activation of NF-κB and JAK-STAT signaling by inflammatory factors in an environment of hypoxia and nutrient deficiency in inflammation (21, 33). This evidence concerns the gene NFKB1 and cancer.